Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · page 41 of 50
The slide uses a bispecific antibody illustration to represent the combination therapy approach.
Deck · key_messages · present_solution · dense density
Slide locked Sign in to view
Slide schematic 7/7
callout 3/3 diagram 1/1 image 1/1 list 1/1 title 1/1
Components 7
primary primary primary timeline illustration bullet headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1